Literature DB >> 30639505

Survival advantage for patients accepting the offer of a circulatory death liver transplant.

Rhiannon Taylor1, Elisa Allen1, James A Richards2, Mingzheng A Goh2, James Neuberger3, David Collett1, Gavin J Pettigrew4.   

Abstract

BACKGROUND & AIMS: Donation after circulatory death (DCD) in the UK has tripled in the last decade. However, outcomes following DCD liver transplantation are worse than for donation after brainstem death (DBD) liver transplants. This study examines whether a recipient should accept a "poorer quality" DCD organ or wait longer for a "better" DBD organ.
METHODS: Data were collected on 5,825 patients who were registered on the elective waiting list for a first adult liver-only transplant and 3,949 patients who received a liver-only transplant in the UK between 1 January 2008 and 31 December 2015. Survival following deceased donor liver transplantation performed between 2008 and 2015 was compared by Cox regression modelling to assess the impact on patient survival of accepting a DCD liver compared to deferring for a potential DBD transplant.
RESULTS: A total of 953 (23%) of the 3,949 liver transplantations performed utilised DCD donors. Five-year post-transplant survival was worse following DCD than DBD transplantation (69.1% [DCD] vs. 78.3% [DBD]; p <0.0001: adjusted hazard ratio [HR] 1.65; 95% CI 1.40-1.94). Of the 5,798 patients registered on the transplant list, 1,325 (23%) died or were removed from the list without receiving a transplant. Patients who received DCD livers had a lower risk-adjusted hazard of death than those who remained on the waiting list for a potential DBD organ (adjusted HR 0.55; 95% CI 0.47-0.65). The greatest survival benefit was in those with the most advanced liver disease (adjusted HR 0.19; 95% CI 0.07-0.50).
CONCLUSIONS: Although DCD liver transplantation leads to worse transplant outcomes than DBD transplantation, the individual's survival is enhanced by accepting a DCD offer, particularly for patients with more severe liver disease. DCD liver transplantation improves overall survival for UK listed patients and should be encouraged. LAY
SUMMARY: This study looks at patients who require a liver transplant to save their lives; this liver can be donated by a person who has died either after their heart has stopped (donation after cardiac death [DCD]) or after the brain has been injured and can no longer support life (donation after brainstem death [DBD]). We know that livers donated after brainstem death function better than those after cardiac death, but there are not enough of these livers for everyone, so we wished to help patients decide whether it was better for them to accept an early offer of a DCD liver than waiting longer to receive a "better" liver from a DBD donor. We found that patients were more likely to survive if they accepted the offer of a liver transplant as soon as possible (DCD or DBD), especially if their liver disease was very severe.
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Donation after brainstem death; Donation after circulatory death; Liver failure; Liver transplantation; Waiting list survival

Year:  2019        PMID: 30639505     DOI: 10.1016/j.jhep.2018.12.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come.

Authors:  Omar Haque; Qing Yuan; Korkut Uygun; James F Markmann
Journal:  Clin Transplant       Date:  2021-01-21       Impact factor: 2.863

2.  Current practice of normothermic regional perfusion and machine perfusion in donation after circulatory death liver transplants in Italy.

Authors:  Riccardo De Carlis; Andrea Lauterio; Leonardo Centonze; Vincenzo Buscemi; Andrea Schlegel; Paolo Muiesan; Luciano De Carlis
Journal:  Updates Surg       Date:  2022-02-28

3.  Recent advances in liver transplantation.

Authors:  N Thomas Burke; James B Maurice; David Nasralla; Jonathan Potts; Rachel Westbrook
Journal:  Frontline Gastroenterol       Date:  2021-04-21

4.  The volume-outcomes relationship in donation after circulatory death liver transplantation.

Authors:  Aaron M Delman; Kevin M Turner; Allison M Ammann; Emily Schepers; Dennis M Vaysburg; Alex R Cortez; Robert M Van Haren; Greg C Wilson; Shimul A Shah; Ralph C Quillin
Journal:  Clin Transplant       Date:  2022-04-25       Impact factor: 3.456

Review 5.  Essential updates 2018/2019: Liver transplantation.

Authors:  Masahiro Ohira; Naoki Tanimine; Tsuyoshi Kobayashi; Hideki Ohdan
Journal:  Ann Gastroenterol Surg       Date:  2020-02-25

Review 6.  Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.

Authors:  Thomas Resch; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Julia Dumfarth; Christoph Krapf; Claudia Boesmueller; Dietmar Oefner; Michael Grimm; Sefan Schneeberger
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

7.  Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma.

Authors:  Allison Kwong; Bilal Hameed; Shareef Syed; Ryan Ho; Hossein Mard; Sahar Arshad; Isaac Ho; Tashfeen Suleman; Francis Yao; Neil Mehta
Journal:  Cancer Med       Date:  2022-01-14       Impact factor: 4.452

8.  The 6 C's of Normothermic Regional Perfusion.

Authors:  James A Richards; Rohit Gaurav; Andrew J Butler; Christopher J E Watson
Journal:  Prog Transplant       Date:  2022-03-18       Impact factor: 1.065

9.  Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study.

Authors:  Marjolein van Reeven; Otto B van Leeuwen; Danny van der Helm; Sarwa Darwish Murad; Aad P van den Berg; Bart van Hoek; Ian P J Alwayn; Wojciech G Polak; Robert J Porte
Journal:  Transpl Int       Date:  2020-03-09       Impact factor: 3.782

10.  Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.

Authors:  Jordyn Silverstein; Garrett Roll; Jennifer L Dodge; Joshua D Grab; Francis Y Yao; Neil Mehta
Journal:  Liver Transpl       Date:  2020-07-21       Impact factor: 5.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.